Immunologic activity and safety of autologous HIV RNA–electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy

Documenti analoghi

• Autologous HIV-1 Clade-B Nef Peptides Elicit Increased Frequency, Breadth and Function of CD8(+) T-Cells Compared to Consensus Peptides
  di: Doroudchi, Mehrnoosh, et al.
  Pubblicazione: (2012)
• P18-13 LB. Immunogenicity of an autologous dendritic cell anti-HIV therapy in HIV-1 infected individuals
  di: Yassine Diab, B, et al.
  Pubblicazione: (2009)
• HIV-1 Viremia Prevents the Establishment of Interleukin 2–producing HIV-specific Memory CD4(+) T Cells Endowed with Proliferative Capacity
  di: Younes, Souheil-Antoine, et al.
  Pubblicazione: (2003)
• siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1 infected individuals
  di: Breton, Gaëlle, et al.
  Pubblicazione: (2009)
• PD-1 is a marker for abnormal distribution of naïve/memory T cell subsets in HIV-1 infection
  di: Breton, Gaëlle, et al.
  Pubblicazione: (2013)